Gastric and rectal administration of encorafenib with targeted chemotherapy against BRAF V600E-mutant rectal cancer with bowel obstruction. - Funk MA; Heinemann V; Bücklein V; Alig SK; Heinrich K; Weiss L; Krenmayr V; Blanchet B; Kunz WG; Theurich S; von Bergwelt-Baildon M; Holch JW (The oncologist, 2026)